Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer
- D. Weisenberger, K. Siegmund, +18 authors P. Laird
- Biology, Medicine
- Nature Genetics
- 1 July 2006
Aberrant DNA methylation of CpG islands has been widely observed in human colorectal tumors and is associated with gene silencing when it occurs in promoter areas. A subset of colorectal tumors has… Expand
Epigenetic stem cell signature in cancer
- M. Widschwendter, H. Fiegl, +8 authors P. Laird
- Biology, Medicine
- Nature Genetics
- 1 February 2007
Embryonic stem cells rely on Polycomb group proteins to reversibly repress genes required for differentiation. We report that stem cell Polycomb group targets are up to 12-fold more likely to have… Expand
Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer.
- A. Teschendorff, Usha Menon, +18 authors M. Widschwendter
- Biology, Medicine
- Genome research
- 1 April 2010
Polycomb group proteins (PCGs) are involved in repression of genes that are required for stem cell differentiation. Recently, it was shown that promoters of PCG target genes (PCGTs) are 12-fold more… Expand
Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer
- Daniel Schramek, A. Leibbrandt, +13 authors J. Penninger
- Medicine
- Nature
- 4 November 2010
Breast cancer is one of the most common cancers in humans and will on average affect up to one in eight women in their lifetime in the United States and Europe. The Women’s Health Initiative and the… Expand
FBXW7/hCDC4 is a general tumor suppressor in human cancer.
- Shahab Akhoondi, D. Sun, +23 authors C. Spruck
- Medicine, Biology
- Cancer research
- 1 October 2007
The ubiquitin-proteasome system is a major regulatory pathway of protein degradation and plays an important role in cellular division. Fbxw7 (or hCdc4), a member of the F-box family of proteins,… Expand
Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer.
- M. Widschwendter, Jennifer Berger, +8 authors C. Marth
- Medicine, Biology
- Journal of the National Cancer Institute
- 17 May 2000
BACKGROUND
A growing body of evidence supports the hypotheses that the retinoic acid receptor beta2 (RAR-beta2) gene is a tumor suppressor gene and that the chemopreventive effects of retinoids are… Expand
DNA methylation and breast carcinogenesis
- M. Widschwendter, P. Jones
- Biology, Medicine
- Oncogene
- 12 August 2002
Knowledge about breast carcinogenesis has accumulated during the last decades but has barely been translated into strategies for early detection or prevention of this common disease. Changes in DNA… Expand
Independent surrogate variable analysis to deconvolve confounding factors in large-scale microarray profiling studies
- A. Teschendorff, Joanna Zhuang, M. Widschwendter
- Biology, Computer Science
- Bioinform.
- 1 June 2011
TLDR
An Epigenetic Signature in Peripheral Blood Predicts Active Ovarian Cancer
- A. Teschendorff, U. Menon, +8 authors M. Widschwendter
- Biology, Medicine
- PloS one
- 18 December 2009
Background Recent studies have shown that DNA methylation (DNAm) markers in peripheral blood may hold promise as diagnostic or early detection/risk markers for epithelial cancers. However, to date no… Expand
Methylation changes in faecal DNA: a marker for colorectal cancer screening?
- H. M. Müller, M. Oberwalder, Heidi Fiegl, M. Morandell, M. Widschwendter
- Medicine
- The Lancet
- 17 April 2004
DNA methylation is a common molecular alteration in colorectal cancer cells. We report an assessment of faecal DNA from patients with colorectal cancer and controls to determine the feasibility,… Expand